borderline significanceP =0.072
Survival analysis of the 37 AML patients revealed that TP53 mutations also had an adverse prognostic impact in AML patients, albeit with borderline significance ( P =0.072; median OS 12.0 vs. 4.4 months) ( Supplemental Data Fig.